date,title,source
Oct-17-18,CORRECTING and REPLACING The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AbbVie Inc. (ABBV),Business Wire
Oct-17-18,SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against AbbVie Inc. - ABBV,ACCESSWIRE
Oct-17-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,ACCESSWIRE
Oct-17-18,Amgen Launches Humira Biosimilar in Europe,GuruFocus.com
Oct-17-18,EyePoint (EYPT) Gets FDA Approval for Eye Therapy Yutiq,Zacks
Oct-18-18,"Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-18-18,AbbVie Falls 3%,Investing.com
Oct-18-18,"Hagens Berman Reminds Investors in AbbVie Inc. (NYSE: ABBV) of the Firms Ongoing Investigation and the November 20, 2018 Securities Class Action Lead Plaintiff Deadline",GlobeNewswire
Oct-18-18,FDA Accepts Application for AbbVie's Imbruvica in Specific Blood Cancers,GuruFocus.com
Oct-19-18,"Investor Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-19-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,GlobeNewswire
Oct-19-18,ABBV NOTICE ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against AbbVie Inc.; Important Deadline  ABBV,GlobeNewswire
Oct-19-18,AbbVie CFO Chase to retire by mid-year 2019,Reuters
Oct-19-18,AbbVie CFO Chase to retire by mid-year 2019,Reuters
Oct-19-18,AbbVie names Robert Michael chief financial officer,Reuters
Oct-19-18,AbbVie CFO Bill Chase to retire,MarketWatch
Oct-22-18,Positive Phase 2b Data for AbbVie's Upadacitinib Show Significant Induction of Clinical Remission and Response in Patients with Ulcerative Colitis,PR Newswire
Oct-22-18,AbbVie Falls 3%,Investing.com
Oct-23-18,AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-23-18,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AbbVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 20, 2018  ABBV",GlobeNewswire
Oct-23-18,"ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In AbbVie, Inc. To Contact The Firm",Business Wire
Oct-23-18,"IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Oct-23-18,AbbVie rheumatoid arthritis drug succeeds in late stage trial,Reuters
Oct-23-18,AbbVie rheumatoid arthritis drug succeeds in late stage trial,Reuters
Oct-23-18,"Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines",Zacks
Oct-23-18,"AbbVie's Upadacitinib Shows Significant Improvements in Physical Function, Pain and Quality of Life as a Monotherapy in Patients with Rheumatoid Arthritis in Phase 3 Patient-Reported Outcomes Data",PR Newswire
Oct-23-18,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",Benzinga
Oct-23-18,Today's Research Reports on Trending Tickers: AbbVie and Endo International,ACCESSWIRE
Oct-24-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,ACCESSWIRE
Oct-24-18,AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program,PR Newswire
Oct-24-18,Galapagos and AbbVie restructure CF collaboration,GlobeNewswire
Oct-24-18,"IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-24-18,AbbVie Falls 3%,Investing.com
Oct-24-18,Healthcare ETFs to Buy Ahead of Q3 Earnings,Zacks
Oct-24-18,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",Benzinga
Oct-24-18,3 Healthcare Stocks I'd Buy Right Now,Motley Fool
Oct-25-18,"IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-25-18,SHAREHOLDER ALERT: MCHP ABBV MGTI HAS ACHC ADNT TRVN HTHT GOOG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Oct-25-18,AbbVie Rises 3%,Investing.com
Oct-25-18,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",Benzinga
Oct-26-18,"Abbott, AbbVie settle TriCor marketing case for $25 mln",Reuters
Oct-26-18,"Abbott, AbbVie settle U.S. case over TriCor marketing for $25 mln",Reuters
Oct-26-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, ACHC, ADNT, HTHT and CWH",GlobeNewswire
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,AbbVie (ABBV) Q3 Earnings Preview: What's Shaping Up?,Zacks
Oct-26-18,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline  November 20, 2018",GlobeNewswire
Oct-29-18,"The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PM, TGTX, ABBV, HTHT and SFIX",GlobeNewswire
Oct-29-18,"IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
Oct-29-18,November 20th AbbVie Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against AbbVie Inc. - ABBV,GlobeNewswire
Oct-29-18,53 Best Dividend Stocks for 2018 and Beyond,Kiplinger
Oct-30-18,"IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-30-18,SHAREHOLDER ALERT: COCP TGTX ABBV ALNY MGTI HAS CPB HTHT SFIX GOOG OZK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Oct-30-18,Why this East Bay drug maker plans to add 300 jobs,American City Business Journals
Oct-30-18,Pawar Law Group Announces a Securities Class Action Lawsuit Against AbbVie Inc. - ABBV,ACCESSWIRE
Oct-30-18,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AbbVie Inc. (NYSE: ABBV) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",GlobeNewswire
Oct-30-18,What's in the Cards for AbbVie (ABBV) This Earnings Season?,Zacks
Oct-31-18,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline  ABBV,ACCESSWIRE
Oct-31-18,"AbbVie, Roche combo treatment meets main goal of leukemia trial",Reuters
Oct-31-18,SHAREHOLDER ALERT: OPK PVG USAT ABBV CHGG ACHC JT ADNT GOOG CWH OZK DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,GlobeNewswire
Oct-31-18,"AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia",PR Newswire
Oct-31-18,AbbVie Falls 3%,Investing.com
Oct-31-18,"SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
Oct-31-18,"CLASS ACTION UPDATE for ABBV, JT and OZK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",GlobeNewswire
Oct-31-18,FDA approves Novartis' copy of AbbVie bestseller Humira,Reuters
Oct-31-18,Neurocrine (NBIX) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-31-18,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline  November 20, 2018",GlobeNewswire
